logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
H

Hitomi Sumiyoshi Okuma

National Cancer Center
H指数:14
被引数:569

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sustained remission after discontinuation of ALK inhibition in ALK-positive histiocytosis

ALK抑制停止后ALK阳性组织细胞增多症的持续缓解

Blood Cancer Journal
IF11.6
2026-04-140
OAAI
Paul G. Kemps; Jennifer L. Picarsic; Sébastien Héritier; Jean Donadieu; Julien Haroche; Laure Farnault; Stefania Gaspari; Dmitry A. Evseev; Daria S. Osipova; Alexander E. Druy; Milen Minkov; Susan Picton; Andreas Beilken; Robert Möhle; Miloš B. Kuzmanović; Hitomi S. Okuma; Chung W. Chow; Martin A. Campbell; Gregory S. Phillips; Yuhang Zhou; Gaurav Goyal; Ronald S. Go; Kee Kiat Yeo; Bryan A. Sisk; Joanna L. Weinstein; Patrick K. Campbell; Eli L. Diamond; Jean-François Emile
RESULTS OF A MULTICENTER PHASE 2 BASKET TRIAL EVALUATING THE EFFICACY OF TASURGRATINIB (E7090) IN PATIENTS WITH ADVANCED SOLID TUMORS WITH FIBROBLAST GROWTH FACTOR RECEPTOR (FGFR) GENE ALTERATION, INCLUDING THOSE WITH PRIMARY BRAIN TUMORS: FORTUNE STUDY

评估TASURGRATINIB（E7090）在具有成纤维细胞生长因子受体（FGFR）基因变异的晚期实体瘤患者（包括原发性脑肿瘤患者）中的疗效的多中心II期篮式试验结果：FORTUNE研究

NEURO-ONCOLOGY
IF13.4
2025-11-010
OAAI
Takahashi, Masamichi; Sudo, Kazuki; Matsubara, Junichi; Tsuchihashi, Kenji; Kinoshita, Ichiro; Takahashi, Masanobu; Chiba, Yohei; Kohsaka, Shinji; Sadachi, Ryo; Machida, Ryunosuke; Ichimura, Masahiko; Okuma, Hitomi Sumiyoshi; Anjo, Kenta; Kurishita, Kazumi; Nakamura, Kenichi; Yonemori, Kan
FGFR2 Fusions or Rearrangements in Young Intrahepatic and Perihilar Cholangiocarcinoma Patients: Key Genetic Insights From a Pan-Asian Study

FGFR2融合或重排在年轻肝内及肝门部胆管癌患者中的关键遗传学见解：一项泛亚洲研究

Hepatology Research
IF3.4
2025-09-160
OAAI
Yuta Maruki; Yasushi Yatabe; Chiharu Mizoguchi; Kathleen Yasmin de Almeida; Aumkhae Sookprasert; Charuwan Akewanlop; Ming-Huang Chen; Ekaphop Sirachainan; Dao Van Tu; Rozita Abdul Malik; Chaiyut Charoentum; Hwoei Fen Soo Hoo; Suhana Yusak; Tsung-Hao Liu; Rangasamy Ramachandran; Patrapim Sunpaweravong; Pei Jye Voon; Najihah Abu Bakar; Junki Mizusawa; Hitomi Sumiyoshi Okuma; Kenichi Nakamura; Chigusa Morizane; Takuji Okusaka
Baseline risk variability by eligibility criteria in Cohort 1 of the monarchE trial for high-risk HR-positive, HER2-negative breast cancer

monarchE试验中高风险HR阳性、HER2阴性乳腺癌队列1的基线风险变异性与纳入标准的关系

Breast Cancer
IF2.9
2025-07-280
OA
Mai Hoshino; Tatsunori Shimoi; Taro Yamanaka; Rui Kitadai; Munehiro Ito; Ayumi Saito; Shosuke Kita; Asuka Kawachi; Hitomi Sumiyoshi Okuma; Aiko Maejima; Yuki Kojima; Kazuki Sudo; Emi Noguchi; Yasuhiro Fujiwara; Jun Kato; Kan Yonemori
Clinicopathological and prognostic features of HER2-null and HER2-low advanced breast cancer treated with eribulin or capecitabine

eribulin或卡培他滨治疗HER2-null和HER2-low晚期乳腺癌的临床病理和预后特征

BREAST CANCER
IF2.9
2024-08-142
OAAI
Kitadai, Rui; Shimoi, Tatsunori; Yazaki, Shu; Okuma, Hitomi Sumiyoshi; Hoshino, Mai; Ito, Munehiro; Saito, Ayumi; Kita, Shosuke; Kojima, Yuki; Nishikawa, Tadaaki; Sudo, Kazuki; Noguchi, Emi; Fujiwara, Yasuhiro; Yoshida, Masayuki; Yonemori, Kan
Lymphocyte-to-monocyte ratio as a prognostic and potential tumor microenvironment indicator in advanced soft tissue sarcoma treated with first-line doxorubicin therapy
SCIENTIFIC REPORTS
IF3.9
2023-07-038
OAAI
Watanabe, Sho; Shimoi, Tatsunori; Nishikawa, Tadaaki; Kawachi, Asuka; Okuma, Hitomi Sumiyoshi; Tokura, Momoko; Yazaki, Shu; Mizoguchi, Chiharu; Arakaki, Motoko; Saito, Ayumi; Kita, Shosuke; Yamamoto, Kasumi; Kojima, Yuki; Sudo, Kazuki; Noguchi, Emi; Yoshida, Akihiko; Kawai, Akira; Fujiwara, Yasuhiro; Yonemori, Kan
Clinical Activity and Exploratory Resistance Mechanism of Milademetan, an MDM2 Inhibitor, in Intimal Sarcoma with MDM2 Amplification: An Open-Label Phase Ib/II Study
CANCER DISCOVERY
IF33.3
2023-06-2714
OA
Koyama, Takafumi; Shimizu, Toshio; Kojima, Yuki; Sudo, Kazuki; Okuma, Hitomi Sumiyoshi; Shimoi, Tatsunori; Ichikawa, Hitoshi; Kohsaka, Shinji; Sadachi, Ryo; Hirakawa, Akihiro; Yoshida, Akihiko; Ando, Reiko Makihara; Ueno, Toshihide; Yanagaki, Mitsuru; Matsui, Naoko; Nakamura, Kenichi; Yamamoto, Noboru; Yonemori, Kan

研究方向

暂未获取到该数据
K
Kan Yonemori
H 指数:48论文数:1,048被引数:1.0万
K
Kazuki Sudo
H 指数:29论文数:491被引数:3,005
Y
Yuki Kojima
H 指数:20论文数:349被引数:1,489
T
Tatsunori Shimoi
H 指数:21论文数:357被引数:2,460
E
Emi Noguchi
H 指数:17论文数:133被引数:1,073
T
Tadaaki Nishikawa
H 指数:17论文数:174被引数:1,747
Y
Yasuhiro Fujiwara
H 指数:65论文数:973被引数:1.7万
A
Ayumi Saito
H 指数:14论文数:94被引数:531
M
Maki Tanioka
H 指数:22论文数:179被引数:1,677
A
Asuka Kawachi
H 指数:15论文数:93被引数:758